Clinical Trials Directory

Trials / Completed

CompletedNCT01146470

The Influence of Red Grape Cells on Blood Pressure Vascular Function in People With Hypertension

A Single-Center, Double-blind, Random, Parallel Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The study hypothesis is that 3 Months Daily Supplementation of RGC will effect blood pressure and vascular function. This will be a single-center, double-blind, random, parallel controlled Study. Study population will include 60 subjects, who will be divided randomly into three groups. The first group will get RGC 200mg, the second group will get RGC 400mg, and the third group will get 200mg placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRGCdosage of Red Grape Cells once a day, during 3 months
DIETARY_SUPPLEMENTPlacebodosage of Placebo once a day, during 3 months

Timeline

Start date
2010-07-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2010-06-17
Last updated
2013-02-20

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01146470. Inclusion in this directory is not an endorsement.